Reference (Aug-20-A1)
1. “Nucleotide Analogues as Probes for DNA and RNA Polymerases” by Robert D. Kuchta, 2010.
2. “Antiviral properties of Phytochemicals” by Ai-Lin Liu and Guan-Hua Du, 2012.
3. “Antiviral natural products and herbal medicines. Journal of Traditional and Complementary Medicine” by Lin et al., 2014.
4. “Antiviral Evaluation of Herbal Drugs”, Book Chapter, 2019.
5. “Zoonotic origins of Human coronaviruses” by Ye et al., 2020.
6. “Emerging SARS-CoV-2 mutation hotspots include a novel RNA-dependent RNA polymerase variant” by Pachetti et al., 2020.
7. “Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach” by Gurung et al.,
2020.
8. “Potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12) of SARS-CoV-2” by Ruan et al., 2020.
9. “Potential therapeutic agents for COVID-19 based on the analysis of protease and RNA polymerase docking” by Chang et al., 2020.
10. “Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent RNA polymerase (RdRp)
inhibition: an in-silico analysis” by Singh et al., 2020.
11. “Natural products may interfere with SARS-CoV-2 attachment to the host cell” by Elfiky, 2020.
12. “Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease”
by Ciavarella et al., 2020.
